304
Tyra Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
257
FY23:
212
FY24:
347
FY25:
265
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.64
FY22:
8.89
FY23:
14.2
FY24:
16.1
FY25:
17.2
Total assets
Change from FY21 to FY25
millions USD
FY21:
307
FY22:
266
FY23:
226
FY24:
364
FY25:
283
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.62
FY22:
5.70
FY23:
15.3
FY24:
14.6
FY25:
18.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.35
FY22:
2.65
FY23:
6.26
FY24:
5.81
FY25:
5.34
(positive)
Change from FY21 to FY25
millions USD
FY21:
302
FY22:
258
FY23:
204
FY24:
343
FY25:
259
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
307
FY22:
266
FY23:
226
FY24:
364
FY25:
283
All amounts in millions USD